Site content

If you would like to download a PDF version of the Product Information Guide please click here

Our Products

First to market and portfolio expansion

The strategy for Mylan in the UK is to identify patented products and endeavour to make them available as a generic on the day of patent expiry. Mylan has an outstanding record of success in introducing off-patent medicines, which is reflected by our extensive product range. We have been first to market with a number of significant off-patent molecules and also look to expand our product range through business development opportunities with other pharmaceutical companies.  

(Last Updated: 28-10-2009)